Neuphoria Therapeutics (NEUP) EBIAT (2024 - 2025)
Historic EBIAT for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q4 2025 value amounting to $1.9 million.
- Neuphoria Therapeutics' EBIAT rose 19592.16% to $1.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$5.7 million, marking a year-over-year change of. This contributed to the annual value of -$400000.0 for FY2025, which is 9741.94% up from last year.
- As of Q4 2025, Neuphoria Therapeutics' EBIAT stood at $1.9 million, which was up 19592.16% from -$9.9 million recorded in Q3 2025.
- Neuphoria Therapeutics' 5-year EBIAT high stood at $11.3 million for Q1 2025, and its period low was -$9.9 million during Q3 2025.